Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Breast Cancer Metastatic × patritumab deruxtecan × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 6 Carcinoma, Non-Small-Cell Lung 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Lung Neoplasms 3 Esophageal Neoplasms 3 Neoplasms 2 Neoplasm Metastasis 2 Brain Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumor, Adult 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Non-Small Cell Lung Cancer Metastatic 1 Meningeal Neoplasms 1 Melanoma 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Cancer 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1

Interventions

Fulvestrant 3 Letrozole 2 tusamitamab ravtansine 1 trastuzumab deruxtecan 1 ribociclib 1 irinotecan sucrosofate 1 exemestane 1 abemaciclib 1 Zoledronic Acid 1 Tamoxifen 1 Paclitaxel 1 Neoadjuvant Therapy 1 Liposomes 1 Irinotecan 1 Gemcitabine 1 Anastrozole 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡